Clinical Trial Update: A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment [Phase 3]

View source ↗

Summary

Phase 3 multicenter randomized non-inferiority trial evaluating an investigational asthma/COPD treatment from Eurofarma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Investigational product by Eurofarma

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Asthma Copd | Phase 3 | Status: COMPLETED